Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carolin Müller

Showing results (81-90 of 103) with videos related to

Pageof 11
Sort By:
The Journal of Physical Chemistry. B|October 7, 2021
Modulating the Excited-State Decay Pathways of Cu(I) 4<i>H</i>-Imidazolate Complexes by Excitation Wavelength and Ligand BackboneBianca Seidler, Maria Sittig, Clara Zens, et al.
Journal of Cancer Research and Clinical Oncology|June 21, 2026
Breast cancer prevention in patients with gBRCA-mutated ovarian cancerNiklas Amann, Annika Krückel, Lena Brückner, et al.
Archives of Gynecology and Obstetrics|October 7, 2024
Impact of low HER2 expression on response to CDK4/6 inhibitor treatment in advanced HR + /HER2- breast cancer: a multicenter real-world data analysisDamian J Ralser, Verena Kiver, Erich-Franz Solomayer, et al.
Journal of Cancer Research and Clinical Oncology|December 17, 2025
Quality of care before and after initial certification at a German certified hereditary breast and ovarian cancer centerNiklas Amann, Manuel Hörner, Henrik Spannring, et al.
Breast Care (Basel, Switzerland)|March 6, 2023
CDK4/6 Inhibitors in Advanced HR+/HER2 - Breast Cancer: A Multicenter Real-World Data AnalysisCarolin Müller, Verena Kiver, Erich-Franz Solomayer, et al.
Breast Cancer Research : BCR|April 1, 2025
Dynamics of T cell subpopulations and plasma cytokines during the first year of antineoplastic therapy in patients with breast cancer: the BEGYN-1 studyElisabeth Kaiser, Regine Weber, Melanie Hirschstein, et al.
ACS Applied Materials & Interfaces|October 12, 2021
Hydrogen Production at a NiO Photocathode Based on a Ruthenium Dye-Cobalt Diimine Dioxime Catalyst Assembly: Insights from Advanced Spectroscopy and Post-operando CharacterizationEmmanouil Giannoudis, Sebastian Bold, Carolin Müller, et al.
Oncotarget|April 21, 2017
Systematic screening of isogenic cancer cells identifies DUSP6 as context-specific synthetic lethal target in melanomaStephanie Wittig-Blaich, Rainer Wittig, Steffen Schmidt, et al.
Annals of Surgical Oncology|April 29, 2022
ASO Author Reflections: An Alternative to Sentinel-Node Biopsy? Preoperative Sonographic Prediction of Limited Axillary Disease in Breast Cancer Patients Meeting the Z0011 CriteriaJulia Caroline Radosa, Erich-Franz Solomayer, Martin Deeken, et al.
Annals of Surgical Oncology|April 29, 2022
Preoperative Sonographic Prediction of Limited Axillary Disease in Patients with Primary Breast Cancer Meeting the Z0011 Criteria: an Alternative to Sentinel Node Biopsy?Julia Caroline Radosa, Erich-Franz Solomayer, Martin Deeken, et al.
Pageof 11

Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
The Journal of Physical Chemistry. B|October 7, 2021
Modulating the Excited-State Decay Pathways of Cu(I) 4<i>H</i>-Imidazolate Complexes by Excitation Wavelength and Ligand BackboneBianca Seidler, Maria Sittig, Clara Zens, et al.
Journal of Cancer Research and Clinical Oncology|June 21, 2026
Breast cancer prevention in patients with gBRCA-mutated ovarian cancerNiklas Amann, Annika Krückel, Lena Brückner, et al.
Archives of Gynecology and Obstetrics|October 7, 2024
Impact of low HER2 expression on response to CDK4/6 inhibitor treatment in advanced HR + /HER2- breast cancer: a multicenter real-world data analysisDamian J Ralser, Verena Kiver, Erich-Franz Solomayer, et al.
Journal of Cancer Research and Clinical Oncology|December 17, 2025
Quality of care before and after initial certification at a German certified hereditary breast and ovarian cancer centerNiklas Amann, Manuel Hörner, Henrik Spannring, et al.
Breast Care (Basel, Switzerland)|March 6, 2023
CDK4/6 Inhibitors in Advanced HR+/HER2 - Breast Cancer: A Multicenter Real-World Data AnalysisCarolin Müller, Verena Kiver, Erich-Franz Solomayer, et al.
Breast Cancer Research : BCR|April 1, 2025
Dynamics of T cell subpopulations and plasma cytokines during the first year of antineoplastic therapy in patients with breast cancer: the BEGYN-1 studyElisabeth Kaiser, Regine Weber, Melanie Hirschstein, et al.
ACS Applied Materials & Interfaces|October 12, 2021
Hydrogen Production at a NiO Photocathode Based on a Ruthenium Dye-Cobalt Diimine Dioxime Catalyst Assembly: Insights from Advanced Spectroscopy and Post-operando CharacterizationEmmanouil Giannoudis, Sebastian Bold, Carolin Müller, et al.
Oncotarget|April 21, 2017
Systematic screening of isogenic cancer cells identifies DUSP6 as context-specific synthetic lethal target in melanomaStephanie Wittig-Blaich, Rainer Wittig, Steffen Schmidt, et al.
Annals of Surgical Oncology|April 29, 2022
ASO Author Reflections: An Alternative to Sentinel-Node Biopsy? Preoperative Sonographic Prediction of Limited Axillary Disease in Breast Cancer Patients Meeting the Z0011 CriteriaJulia Caroline Radosa, Erich-Franz Solomayer, Martin Deeken, et al.
Annals of Surgical Oncology|April 29, 2022
Preoperative Sonographic Prediction of Limited Axillary Disease in Patients with Primary Breast Cancer Meeting the Z0011 Criteria: an Alternative to Sentinel Node Biopsy?Julia Caroline Radosa, Erich-Franz Solomayer, Martin Deeken, et al.
Pageof 11